Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo-controlled Parallel-group Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UC1010 Administered Subcutaneously, Single-dosing in Healthy Women (Part 1) and Multiple Dosing in PMDD Women (Part 2) - Phase I/II Study

Next Previous
X
Search
Trial Profile

A Randomized, Double-blind, Placebo-controlled Parallel-group Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UC1010 Administered Subcutaneously, Single-dosing in Healthy Women (Part 1) and Multiple Dosing in PMDD Women (Part 2) - Phase I/II Study

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sepranolone (Primary)
  • Indications Premenstrual dysphoric disorder
  • Focus First in man; Pharmacokinetics; Therapeutic Use
  • Sponsors Asarina Pharma; Umecrine Mood

    • Most Recent Events

    • 01 Jun 2017 Secondary outcome measures also included, Negative mood score i.e. the ratings of the 4 key symptoms in PMDD(anger/irritability, depression, anxiety and lability) and impairment (impact on daily life), according to results published in the Psychoneuroendocrinology Journal.
    • 19 Sep 2015 Primary endpoint [Symptom assessment using a validated daily rating scale (DRSP) containing the demanded symptoms in DSM-IV for diagnosis of PMDD (Premenstrual symptom severity] has not been met.
    • 26 Jul 2014 Status changed from active, no longer recruiting to completed, as per European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top